Email This Press Releases

NASDAQ:SPRY Investor Notice: Investigation over Potential Securities Laws Violations by ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc. is under investigation on over potential securities laws violations in connection with certain financial statements.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy